NSAIDs and Upper Gastrointestinal Bleeding

References

• 1 Rollhauser C, Fleischer D E. Nonvariceal upper gastrointestinal bleeding.  Endoscopy. 2002;  34 111-118
• 2 Higham J, Kang J Y, Majeed A. Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects.  Gut. 2002;  50 460-464
• 3 Gabriel S E, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: a meta-analysis.  Ann Intern Med. 1991;  115 787-796
• 4 Silverstein F E, Graham D Y, Senior J R. et al . Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: a randomized, double-blind, placebo-controlled trial.  Ann Intern Med. 1995;  123 241-249
• 5 Lanza L L, Walker A M, Bortnichak E A, Dreyer N A. Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years: a large health maintenance organization cohort study.  Arch Intern Med. 1995;  155 1371-1377
• 6 Hansen J M, Hallas J, Lauritsen J M, Bytzer P. Non-steroidal anti-inflammatory drugs and ulcer complications: a risk factor analysis for clinical decision-making.  Scand J Gastroenterol. 1996;  31 126-130
• 7 Mamdani M, Rochon P A, Juurlink D N. et al . Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs.  Br Med J. 2002;  325 624-627
• 8 Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient.  Gastroenterology. 2001;  120 594-606
• 9 Henry D, Lim L LY, Rodriguez L AG. et al . Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis.  Br Med J. 1996;  312 1563-1566
• 10 Juni P, Rutjes A W, Dieppe P A. Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?.  Br Med J. 2002;  324 1287-1288
• 11 Budenholzer B R, Geis G S, Mamdani M. et al . Are selective COX 2 inhibitors superior to traditional NSAIDs?.  Br Med J. 2002;  325 161-163
• 12 Deeks J J, Smith L A, Bradley M D. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.  Br Med J. 2002;  25 619-623
• 13 Andersen I B, Jorgensen T, Bonnevie O. et al . Smoking and alcohol intake as risk factors for bleeding and perforated peptic ulcers: a population-based cohort study.  Epidemiology. 2000;  11 434-439
• 14 Rollhauser C, Fleischer D E. Current status of endoscopic therapy for ulcer bleeding.  Baillière's Best Pract Res Clin Gastroenterol. 2000;  14 391-410